Berit Jul Mosgaard

Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials

Ignace Vergote, Corneel Coens, Matthew Nankivell et al. · The Lancet Oncology · 2018 · 290 citations · Full text

Surgical Oncology, Gynecological Surgery, Individual Patient Data +10

Stage at diagnosis and ovarian cancer survival: Evidence from the International Cancer Benchmarking Partnership

Camille Maringe, Sarah Walters, John Butler et al. · Gynecologic Oncology · 2012 · 206 citations

Ovarian Cancer Survival, Cancer Detection, Medicine +8

Infertility, fertility drugs, and invasive ovarian cancer: a case-control study

Berit Jul Mosgaard, Øjvind Lidegaard, Geert Schou et al. · Fertility and Sterility · 1997 · 206 citations · Full text

Infertility, Andrology, Hormonal Contraceptive +12

TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7)

Andreas du Bois, Philipp Harter, Christina Fotopoulou et al. · International Journal of Gynecological Cancer · 2019 · 167 citations

Primary cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: OVHIPEC-2, a phase III randomized clinical trial

Simone N. Koole, Ruby M. van Stein, Karolina Sikorska et al. · International Journal of Gynecological Cancer · 2020 · 96 citations · Full text